Piper Sandler lowered shares of Turnstone Biologics (NASDAQ:TSBX – Free Report) from an overweight rating to a neutral rating in a research report released on Wednesday, Marketbeat.com reports. The ...
Piper Sandler adjusted its outlook on Microchip Technology (NASDAQ:MCHP) shares, reducing the price target to $65 from the previous $85 while maintaining an Overweight rating on the stock. The firm's ...
Piper Sandler analyst Rob Owens increased the price target on Fortinet stock (NASDAQ:FTNT) to $135 from $120, while maintaining an Overweight rating. Owens highlighted the company's strong product ...
Piper Sandler analyst Harsh Kumar adjusted the price target for AMD (NASDAQ:AMD) shares to $140 from the previous $180 while keeping an Overweight rating on the stock. The revision reflects lowered ...
Piper Sandler analyst Justin Crowley initiated coverage on Shore Bancshares (NASDAQ:SHBI) with an Overweight rating, setting a price target of $20.00. The firm highlighted the bank's strong presence ...
Piper Sandler adjusted its financial outlook for Amazon.com (NASDAQ:AMZN), increasing the price target to $265 from the previous $225, while maintaining an Overweight rating on the company's shares.
Piper Sandler restated their overweight rating on shares of Intapp (NASDAQ:INTA – Free Report) in a research report sent to investors on Tuesday morning,Benzinga reports. Piper Sandler currently has a ...
Piper Sandler, a financial services firm, increased its price target for CyberArk Software (NASDAQ:CYBR) stock, setting the new goal at $440, up from the previous target of $380, while maintaining an ...
Piper Sandler expressed continued confidence in Amplitude Inc (NASDAQ:AMPL), maintaining an Overweight rating and a $15.00 ...
Fintel reports that on January 31, 2025, Piper Sandler downgraded their outlook for Hershey (WBAG:HSY) from Neutral to Underweight. There are 2,171 funds or institutions reporting positions in ...
Piper Sandler adjusted the price target for Mondelez International (NASDAQ:MDLZ) shares, reducing it to $56 from the previous $63, while retaining a Neutral rating on the stock. The stock, currently ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results